课题基金 / 基金详情

Involvement of alpha2 subunit-containing GABAA receptors in circuits underlying drug abuse

Involvement of alpha2 subunit-containing GABAA receptors in circuits underlying drug abuse
含有 α2 亚基的 GABAA 受体参与药物滥用的回路
批准号:
G0600874/1
负责人:
David Stephens
金额:
$42.02万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --

项目摘要

项目成果

David Stephens的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abused drugs such as cocaine and heroin act to facilitate the workings of particular nerve cells that use the chemical messenger, dopamine to communicate with other nerve cells. Dopamine cells have been described by some researchers as forming part of the reward circuitry of the brain. One of the most important kinds of nerve cell with which dopamine cells communicate uses a different chemical messenger, GABA. Drugs such as alcohol and benzodiazepines have their effects on GABA systems. Compared to studies of dopamine, relatively little research has been invested into the function of the GABA system in reward. This project will use mice that have been genetically altered so that particular aspects of GABA signalling are compromised. Specifically, it will investigate the importance of those GABA systems that use GABA receptors that contain the so-called alpha 2 protein, since these kinds of receptor are found in the brain areas involved in learning about the circumstances in which rewards are encountered. Preliminary research suggests that mice genetically engineered so that they cannot make the alpha 2 protein do not show the behavioural adaptations that normal mice display when they repeatedly receive cocaine, which suggests they may not be capable of some kinds of learning about rewards (incentive learning). The project will confirm these preliminary observations, and test the idea in more rigorous, but technically more difficult animal models of drug abuse. If alpha 2-containing GABA receptors can be shown to play an important role in learning about drug rewards, then it may be possible to develop drugs that disable these receptors as a treatment for drug abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional interplay of ciliary trafficking complexes and motor proteins.
  • 批准号:
    BB/S013024/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $59.61万
  • 财政年份:
    2019
  • 负责人:
    David Stephens
  • 依托单位:
High-resolution imaging and time-resolved proteomic profiling of COPII-dependent procollagen packaging.
  • 批准号:
    MR/P000177/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $58.94万
  • 财政年份:
    2016
  • 负责人:
    David Stephens
  • 依托单位:
The dynein-2 microtubule motor
  • 批准号:
    BB/N000420/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $47.83万
  • 财政年份:
    2016
  • 负责人:
    David Stephens
  • 依托单位:
The Golgi apparatus as an initiator of ciliogenesis
  • 批准号:
    MR/K018019/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $46.95万
  • 财政年份:
    2013
  • 负责人:
    David Stephens
  • 依托单位:
国内基金
海外基金
钛合金中alpha相保载效应影响因素研究
  • 批准号:
    51701219
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2017
  • 负责人:
    邱建科
  • 依托单位:
锌alpha2糖蛋白对非酒精性脂肪肝的保护作用及机制研究
  • 批准号:
    81270925
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2012
  • 负责人:
    肖新华
  • 依托单位:
Alpha2肾上腺素受体异常表达和激活致喉源性窒息的中枢机制及在阻塞性睡眠呼吸暂停发生中的作用
  • 批准号:
    81270060
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2012
  • 负责人:
    王继江
  • 依托单位:
阻断alpha2肾上腺素能受体抑制脓毒症性心功能障碍的作用环节研究
  • 批准号:
    81170222
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2011
  • 负责人:
    王华东
  • 依托单位: